BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32100534)

  • 1. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease.
    Zheng YY; Wu TT; Liu ZQ; Li A; Guo QQ; Ma YY; Zhang ZL; Xun YL; Zhang JC; Wang WR; Kadir P; Wang DY; Ma YT; Zhang JY; Xie X
    J Agric Food Chem; 2020 Mar; 68(11):3548-3557. PubMed ID: 32100534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
    Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
    Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levels.
    Liang M; Liu J; Chen W; He Y; Kahaer M; Li R; Tian T; Liu Y; Bai B; Cui Y; Yang S; Xiong W; Ma Y; Zhang B; Sun Y
    Front Endocrinol (Lausanne); 2022; 13():925119. PubMed ID: 36237183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiome as non-invasive biomarkers for identifying overweight people at risk for osteoarthritis.
    Wang Z; Zhu H; Jiang Q; Zhu YZ
    Microb Pathog; 2021 Aug; 157():104976. PubMed ID: 34023440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome-based noninvasive diagnostic model to predict acute coronary syndromes.
    Wang J; Hu Z; Xu Q; Shi Y; Cao X; Ma Y; Wang M; Zhang C; Luo X; Lin F; Li X; Duan Y; Cai H
    Front Cell Infect Microbiol; 2023; 13():1305375. PubMed ID: 38298920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the gut mycobiome with coronary artery disease severity.
    An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
    EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery disease is associated with an altered gut microbiome composition.
    Toya T; Corban MT; Marrietta E; Horwath IE; Lerman LO; Murray JA; Lerman A
    PLoS One; 2020; 15(1):e0227147. PubMed ID: 31995569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
    Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
    J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
    Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
    J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study.
    Pan R; Zhang X; Gao J; Yi W; Wei Q; Su H
    Psychiatry Res; 2020 Sep; 291():113260. PubMed ID: 32763534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis.
    Xu Z; Xie Z; Sun J; Huang S; Chen Y; Li C; Sun X; Xia B; Tian L; Guo C; Li F; Pi G
    Front Cell Infect Microbiol; 2020; 10():160. PubMed ID: 32373553
    [No Abstract]   [Full Text] [Related]  

  • 14. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
    Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
    Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
    Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
    J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
    Gokulakrishnan K; Nikhil J; Viswanath B; Thirumoorthy C; Narasimhan S; Devarajan B; Joseph E; David AKD; Sharma S; Vasudevan K; Sreeraj VS; Holla B; Shivakumar V; Debnath M; Venkatasubramanian G; Varambally S
    J Psychiatr Res; 2023 Jun; 162():140-149. PubMed ID: 37156128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis.
    Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI
    Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
    Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
    Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals.
    Cui G; Liu S; Liu Z; Chen Y; Wu T; Lou J; Wang H; Zou Y; Sun Y; Rao B; Ren Z; Lian Y; Jiang Y
    Front Microbiol; 2021; 12():696632. PubMed ID: 35069460
    [No Abstract]   [Full Text] [Related]  

  • 20. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
    Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
    Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.